Key result
Intravenous nitroglycerine was confirmed to be clinically effective and safe for managing posttreatment hypertension during electroconvulsive therapy in a review of a series of treatments.
Why the study?
Does intravenous nitroglycerine safely and effectively manage posttreatment hypertension in patients undergoing electroconvulsive therapy?
Does intravenous nitroglycerine safely and effectively manage posttreatment hypertension in patients undergoing electroconvulsive therapy?
Answers are grounded in this paper and cite their sources.
Intravenous nitroglycerine appears to be a safe and effective pharmacological strategy for managing the acute hypertensive pressor response following electroconvulsive therapy.
Intravenous nitroglycerine is not described in the psychiatric literature for management of the inevitable and potentially dangerous pressor response encountered in electroconvulsive treatment. However, the anesthesia literature has documented the use of nitroglycerine for the management of similar catecholamine-based hypertension. Unlike other approaches, nitroglycerine creates a controlled, significant, brief vasodilatation after convulsive treatment accompanied by desirable coronary vasodilatation without increased cardiac stress. A review of a series of treatments in which this technique was used confirms the clinical efficacy and safety of this approach.
No takes yet. Share an insight, caveat, or question.
JEFFRY R. NURENBERG (1991) conducted a review in Posttreatment hypertension during electroconvulsive therapy. Intravenous nitroglycerine was evaluated on Clinical efficacy and safety. Intravenous nitroglycerine was confirmed to be clinically effective and safe for managing posttreatment hypertension during electroconvulsive therapy in a review of a series of treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: